Verdad Advisers’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$644K Sell
3,795
-9,963
-72% -$1.62M 0.69% 46
2026
Q2
$2.12M Sell
13,758
-55
-0.4% -$8.43K 2.03% 2
2026
Q1
$2.2M Buy
+13,813
New +$2.32M 2.48% 1

Other funds holding BLTE

Verdad Advisers's BLTE Position: Q3 2026 in Review

Verdad Advisers reduced its Belite Bio (BLTE) stake by 72% in Q3 2026, selling an estimated $1.62M and leaving 3,795 shares worth $644K. The position accounts for 0.69% of the portfolio, ranked #46.

Verdad Advisers first reported a position in BLTE in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.2M in Q1 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Verdad Advisers held 3,795 shares of Belite Bio worth $644K as of Q3 2026.
  • Verdad Advisers sold 9,963 Belite Bio shares in Q3 2026, an estimated $1.62M.
  • Belite Bio made up 0.69% of Verdad Advisers's portfolio in Q3 2026, its #46 holding.
  • Verdad Advisers first reported a position in Belite Bio in Q1 2026 and has held it in 3 quarters since.
  • Verdad Advisers's Belite Bio position peaked at $2.2M in Q1 2026.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Verdad Advisers's 13F filing for Q3 2026, filed 16 Nov 2026.